Esophageal squamous cell carcinoma
Conditions
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age not limited, gender not limited, expected survival period >=1 year; 2.Patients who underwent esophageal ESD at Zhongshan Hospital affiliated with Fudan University from January 1, 2011 to December 31, 2024; 3.The final pathological examination of the patient showed esophageal squamous cell carcinoma and did not break through the submucosal layer (i.e. T1a and T1b); 4.The subjects voluntarily joined this study, obtained verbal consent or signed informed consent forms, had good compliance, and cooperated with follow-up;.
Exclusion criteria
Exclusion criteria: 1.Perform neoadjuvant therapy before ESD surgery; 2.Postoperative pathology shows adenocarcinoma or tumor breakthrough through the submucosal layer; 3.Patients with mental illness or a history of substance abuse; 4.Patients with incomplete clinical data or lost to follow-up; 5.Patients deemed unsuitable for inclusion by the attending physician,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of quality of life;Progression free survival; | — |
Countries
China
Contacts
Public ContactPing-Hong Zhou
Zhongshan Hospital, Fudan University
Outcome results
None listed